| Ytd | -53.27% | |
| 1y | 4.50% |
| Open | 4.66 | Prev Close | 4.63 | Low | 4.56 | High | 4.72 | Mkt Cap | 364.34M |
| Vol | 214.47K | Avg Vol | 923.87K | EPS | -1.45 | P/E | -3.20 | Forward P/E | -2.24 |
| Beta | 1.46 | Short Ratio | 6.55 | Inst. Own | 91.48% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-11 | 50-d Avg | 4.63 | 200-d Avg | 6.79 | 1yr Est | 22.29 |
RMAT designation granted based on recent interim clinical data from ongoing Phase I/II clinical tria
U.S. stock futures mixed, Dow futures up 100 pts. Fermi Inc (FRMI) shares down 20.4% in pre-market a